Risk EValuation And Its Impact on ClinicAL Decision Making and Outcomes in Heart Failure

NACompletedINTERVENTIONAL
Enrollment

3,124

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Heart Failure
Interventions
BEHAVIORAL

Electronic Alert

"Patients randomized to the intervention will have an alert of their prognosis based on the best available prognostic models for inpatient and 1-year mortality generated with information from their electronic health record, which will consist of a pop-up when the provider accesses a patient record to enter a progress note after the definitions for inclusions into the study have been registered."

Trial Locations (1)

06510

Yale New Haven Hospital, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT03845660 - Risk EValuation And Its Impact on ClinicAL Decision Making and Outcomes in Heart Failure | Biotech Hunter | Biotech Hunter